Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involving Abilify
Published by Food and Drug Administration News March 31st, 2008 in UncategorizedOtsuka American Pharmaceutical Inc., the U.S. subsidiary of Japanese pharmaceutical manufacturer Otsuka Pharmaceutical Co., Ltd., has agreed to pay more than $4 million to resolve allegations that it marketed ... via Med Ad News